We discovered that MISP was significantly upregulated in lung cancers relative to adjacent counterparts (Figure1A; Figure S1A, Supporting Information), and was correlated with shorter patient survival and disease‐free times (Figure 1B,C). Here, MISP is linked to lung carcinoma.